The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, double-blind, phase II study of first-line FOLFOX plus bevacizumab with onartuzumab versus placebo in patients with metastatic colorectal cancer (mCRC).
 
Johanna C. Bendell
No Relationships to Disclose
 
Howard S. Hochster
Consulting or Advisory Role - Genentech
 
Lowell L. Hart
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst)
 
Irfan Firdaus
No Relationships to Disclose
 
Joseph Ronald Mace
No Relationships to Disclose
 
Joshua Jemison McFarlane
No Relationships to Disclose
 
Mark Kozloff
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
 
Daniel Virgil Thomas Catenacci
Honoraria - Genentech
Consulting or Advisory Role - Genentech
 
Jessie J. Hsu
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Stephen Paul Hack
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
David S. Shames
Employment - Genentech
 
See-Chun Phan
Employment - Genentech
 
Allen Lee Cohn
Honoraria - Celgene; onyx; Sanofi
Speakers' Bureau - Celgene; Lilly; Sanofi